ImmuPharma Property Plant And Equipment Net from 2010 to 2025

IMM Stock   4.00  0.10  2.56%   
ImmuPharma PLC's Property Plant And Equipment Net is increasing over the years with slightly volatile fluctuation. Overall, Property Plant And Equipment Net is expected to go to about 181.9 K this year. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects ImmuPharma PLC's investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2006-03-31
Previous Quarter
87.6 K
Current Value
87.6 K
Quarterly Volatility
126.7 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ImmuPharma PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImmuPharma PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.5 K, Interest Expense of 2.2 K or Selling General Administrative of 1.7 M, as well as many indicators such as . ImmuPharma financial statements analysis is a perfect complement when working with ImmuPharma PLC Valuation or Volatility modules.
  
This module can also supplement various ImmuPharma PLC Technical models . Check out the analysis of ImmuPharma PLC Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in ImmuPharma Stock

ImmuPharma PLC financial ratios help investors to determine whether ImmuPharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImmuPharma with respect to the benefits of owning ImmuPharma PLC security.